Human Papillomavirus (HPV) is the primary cause of cervical, anal, vulvar, vaginal and penile cancers as well as genital warts. To date, two prophylactic HPV vaccines are currently available in the Canadian market namely Gardasil and Cervarix. Gardasil, (approved in Canada July 2006) is Mercks quadrivalent HPV recombinant vaccine against HPV types 6, 11, 16 and 18.
OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society.
Last date updated on August, 2021